TrialInternational journal of hematology2012

Safety and feasibility of high-dose ranimustine (MCNU), carboplatin, etoposide, and cyclophosphamide (MCVC) therapy followed by autologous stem cell transplantation for malignant lymphoma.

Yoshihiro Kameoka et al.PubMed ↗Publisher ↗

No numbers read from the abstract.